Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
CAS RN: | Product Number: B6160
BGP-15 Hydrochloride
Purity: >98.0%(HPLC)
- N-[2-Hydroxy-3-(piperidin-1-yl)propoxy]nicotinimidamide Hydrochloride
- N-[2-Hydroxy-3-(1-piperidinyl)propoxy]-3-pyridinecarboximidamide Hydrochloride
- NP-51 Hydrochloride
Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
---|---|---|---|---|---|
5MG |
$105.00
|
Contact Us | Contact Us | 26 |
|
25MG |
$368.00
|
Contact Us | Contact Us | 32 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | B6160 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__4H__2__2N__4O__2·xHCl |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Hygroscopic |
Related CAS RN | 459809-32-6&66611-37-8 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Melting point | 200.0 to 204.0 °C |
NMR | confirm to structure |
Melting Point | 202 °C |
HS Number | 2933.39.9200 |
References
- 1) Role of PARP Inhibitors in Cancer Biology and Therapy
- 2) Effect of Poly(ADP-Ribose) Polymerase Inhibitors on the Ischemia-Reperfusion-Induced Oxidative Cell Damage and Mitochondrial Metabolism in Langendorff Heart Perfusion System
- 3) HSP72 protects against obesity-induced insulin resistance
- 4) Pharmacological overview of the BGP-15 chemical agent as a new drug candidate for the treatment of symptoms of metabolic syndrome
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.